Clinical Trial Update: Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing carboplatin, paclitaxel, and radiation with or without thalidomide in stage III non-small cell lung cancer was terminated and results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• Thalidomide (thalidomide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Lung Cancer | Phase 3 | Status: TERMINATED | Results posted: 2012-03-22